Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × Lymphoid × Clear all

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Phase 2 Unknown

15 enrolled

BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03012620 2024-02-28

AcSé

Phase 2 Completed

334 enrolled

CNSEndocrineGynecologicHead & NeckLymphoidSarcoma

Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Carcinoma, Neuroendocrine, Lymphoma, Extranodal NK-T-Cell

NCT02113800 2020-10-28

EVINEC

Phase 2 Completed

40 enrolled

EndocrineLymphoidNET

Lymphoma, Follicular, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT03147404 2019-12-30

MS100070-0177

Phase 2 Completed

14 enrolled

EndocrineLymphoid

Lymphoma, Follicular, Carcinoma, Neuroendocrine

Clinical Trials

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

AcSé

EVINEC

MS100070-0177